Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00883
|
|||||
| Drug Name |
Camostat
|
|||||
| Synonyms |
0FD207WKDU; 4-(2-(2-(Dimethylamino)-2-oxoethoxy)-2-oxoethyl)phenyl 4-guanidinobenzoate; 59721-28-7; C20H22N4O5; CCRIS 7219; CHEMBL85164; Camostat; Camostat (INN); Camostat [INN]; Camostatum; Camostatum [INN-Latin]; Dimethylcarbamoylmethyl 4-(4-guqnidinobenzoyloxy)phenylacetat; FOY 305; FOY-305; Foipan; UNII-0FD207WKDU; [4-[2-[2-(dimethylamino)-2-oxoethoxy]-2-oxoethyl]phenyl] 4-(diaminomethylideneamino)benzoate; camostate; camostate-mesilate; foypan; p-Guanidinobenzoic acid, ester with (p-hydroxyphenyl)acetic acid, ester with N
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Chronic pancreatitis [ICD11: DC32] | Approved | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C20H22N4O5
|
|||||
| Canonical SMILES |
CN(C)C(=O)COC(=O)CC1=CC=C(C=C1)OC(=O)C2=CC=C(C=C2)N=C(N)N
|
|||||
| InChI |
InChI=1S/C20H22N4O5/c1-24(2)17(25)12-28-18(26)11-13-3-9-16(10-4-13)29-19(27)14-5-7-15(8-6-14)23-20(21)22/h3-10H,11-12H2,1-2H3,(H4,21,22,23)
|
|||||
| InChIKey |
XASIMHXSUQUHLV-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 59721-29-8
|
|||||
| Pharmaceutical Properties | Molecular Weight | 398.4 | Topological Polar Surface Area | 137 | ||
| Heavy Atom Count | 29 | Rotatable Bond Count | 9 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 6 | |||
| XLogP |
1.1
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:135632
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | OCT-1 | Transporter Info | Organic cation transporter 1 | Substrate | [2] | |
| References | ||||||
| 1 | Wikipedia: Camostat | |||||
| 2 | Identification of novel substrates and structure-activity relationship of cellular uptake mediated by human organic cation transporters 1 and 2. J Med Chem. 2013 Sep 26;56(18):7232-42. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.